JAK2V617F activating mutation is associated with the...

JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia

Pich, A, Riera, L, Sismondi, F, Godio, L, Bonino, L D., Marmont, F, di Celle, P F.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
62
Language:
english
Journal:
Journal of Clinical Pathology
DOI:
10.1136/jcp.2009.065904
Date:
September, 2009
File:
PDF, 929 KB
english, 2009
Conversion to is in progress
Conversion to is failed